biomicroscopy and stereoscopic photography are subjective and insensitive to small changes in retinal thickness ] 5[ Measurement of the integrity of t

Similar documents
Study of clinical significance of optical coherence tomography in diagnosis & management of diabetic macular edema

OCT Assessment of the Vitreoretinal Relationship in CSME

Recalcitrant Diabetic Macular Oedema: Therapeutic Options

ROLE OF LASER PHOTOCOAGULATION VERSUS INTRAVITREAL TRIAMCINOLONE ACETONIDE IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETES MELLITUS

Clinically Significant Macular Edema (CSME)

Andrew J. Barkmeier, MD; Benjamin P. Nicholson, MA; Levent Akduman, MD

Is OCT-A Needed As An Investigative Tool During The Management Of Diabetic Macular Edema

JMSCR Vol 06 Issue 12 Page December 2018

VISUAL OUTCOME IN DIABETIC MACULAR EDEMA AFTER GRID LASER TREATMENT

COMPARISON OF INTRAVITREAL TRIAMCINOLONE INJECTION VS LASER PHOTOCOAGULATION IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETIC RETINOPATHY

Optical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN)

Role of OCT in the diagnosis and follow up of diabetic macular edema

Optical Coherence Tomography in Diabetic Retinopathy. Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP

Diagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City

Eyes on Diabetics: How to Avoid Blindness in Diabetic Patient

Subclinical Diabetic Macular Edema Study

Case Report Inherent Challenges in Managing Long Standing Refractory Diabetic Macular Edema

A retrospective nonrandomized study was conducted at 3

OCT in Diabetic Macular Edema and its Correlation with Flourescein Angiography

Diabetic Management beyond traditional risk factors and LDL-C control: Can we improve macro and microvascular risks?


THE ROLE OF anti-vegf IN DIABETIC RETINOPATHY AND AGE RELATED MACULAR DEGENERATION

Optical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D.

3/6/2014. Hoda MH Mostafa MD Associate Professor of Ophthalmology Cairo University. The author has no proprietary interest. Today s Objectives

Optical coherence tomography in diabetic macular edema: patterns and related risk factors

IQ 532 Micropulse Green Laser treatment for Refractory Chronic Central Serous Retinopathy

The Human Eye. Cornea Iris. Pupil. Lens. Retina

Fundus Fluorescein Angiography in Diabetic Retinopathy: Correlation of Angiographic Findings to the Clinical Maculopathy Abstract: Purpose:

EFFICACY OF INTRAVITREAL TRIAMCINOLONE ACETONIDE FOR THE TREATMENT OF DIABETIC MACULAR EDEMA

Scott M. Pfahler D.O. Dayton Vitreo-Retinal Associates AOCOO-HNS Palm Springs, CA 2012

Moncef Khairallah, MD

Intravitreal bevacizumab for pediatric exudative retinal diseases

Clinical spectrum of lamellar macular defects including pseudoholes and pseudocysts defined by optical coherence tomography

R&M Solutions

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health Technology Appraisal. Aflibercept for treating diabetic macular oedema.

ORIGINAL ARTICLE. Introduction. June 2009 Kerala Journal of Ophthalmology 139

When optical coherence tomography (OCT)

Case Report Increase in Central Retinal Edema after Subthreshold Diode Micropulse Laser Treatment of Chronic Central Serous Chorioretinopathy

Ophthalmology Macular Pathways

Intravitreal Monotherapy with Bevacizumab and Triamcinolone Versus Combination Therapy in Recalcitiant Diabetic Macular Edema

OPTIC DISC PIT Pathogenesis and Management OPTIC DISC PIT

Clinical Outcomes After Intravitreal Bevacizumab Injection for Diabetic Macular Edema

Diabetic maculopathy 11/ An update on. Miss Vasuki Sivagnanavel

Optical Coherence Tomography of the Retina. New Technology - New Insights

Diabetic and the Eye: An Introduction

Diabetic Maculopathy in Nonproliferative Diabetic Retinopathy in Tertiary Eye Care Hospital in India: A Prospective Nonrandomized Clinical Study

Fundus Autoflu ores cence Findings Pre and Post Intravitreal Bevacizumab Injection in Patients with Diabetic Macular Edema

Published on Points de Vue International Review of Ophthalmic Optics (

Evaluation of Changes of Macular Thickness in Diabetic Retinopathy after Cataract Surgery

Clinical Trials in Diabetic Retinopathy. Harry W. Flynn Jr., M.D. Nidhi Relhan Batra, M.D.

PART 1: GENERAL RETINAL ANATOMY

Diabetic Retinopathy: Managing the Extremes. J. Michael Jumper, MD West Coast Retina

Automated Detection of Clinically Significant Macular Edema by Grid Scanning Optical Coherence Tomography

Serious Eye diseases, New treatments. Mr. M. Usman Saeed MBBS, FRCS, FRCOphth Consultant Ophthalmologist

Yasser R. Serag, MD Tamer Wasfi, MD El- Saied El-Dessoukey, MD Magdi S. Moussa, MD Anselm Kampik, MD

EPIRETINAL MEMBRANE & VITREOMACULAR TRACTION

Paradigm Shift in the treatment of Diabetic Retinopathy. Haytham I. S. Salti, MD Associate Professor

RETINAL THICKENING MAY BE PRESENT IN A NUMBER. B-scan Ultrasonography for the Detection of Macular Thickening METHODS

Classification of diabetic retinopathy and diabetic macular edema

Intravitreal versus Posterior Subtenon Injection of Triamcinolone Acetonide for Diabetic Macular Edema

CENTRAL SEROUS CHORIORETINOPATHY (CSC) IS

Diabetic Macular Edema Treatment in the 21st Century

INTRODUCTION. Trans Am Ophthalmol Soc 2010;108:62-76

New Developments in the treatment of Diabetic Retinopathy

Diabetic retinopathy (DR) progressively

DIABETIC RETINOPATHY (DR) PREFERRED PRACTICE PATTERNS (PPP) Philippines 2016

Opthea Initiates OPT-302 Diabetic Macular Edema Clinical Trial

Use of Scanning Laser Ophthalmoscope Microperimetry in Clinically Significant Macular Edema in Type 2 Diabetes Mellitus

Novel imaging techniques for diabetic macular edema

Jay M. Haynie, O.D.; F.A.A.O. Olympia Tacoma Renton Kennewick Washington

The effect of intravitreal bevacizumab in a rare case of retinal dystrophy with secondary cystoid macular edema

DOME SHAPED MACULOPATHY. Ιωάννης Ν. Βαγγελόπουλος Χειρ. Οφθαλμίατρος - Βόλος

To Study the correlation between fundus fluorescein angiography and optical coherence tomography patterns in clinically significant macular oedema

LEE EYE CENTRE. YOUR VISION, OUR PASSION LEC EyeNews

Diabetic Retinopathy Clinical Research Network

Diabetic Retinopathy A Presentation for the Public

Facts About Diabetic Eye Disease

Case Report Macular Oedema Related to Idiopathic Macular Telangiectasia Type 1 Treated with Dexamethasone Intravitreal Implant (Ozurdex)

Case report 12/10/2014. Delphine Lam ; Dr Mayer Srour Service d ophtalmologie Professeur E.Souied Université Paris Est

Natural Short-term Course of Recurrent Macular Edema Following Intravitreal Bevacizumab Therapy in Branch Retinal Vein Occlusion

Technologies and Methods for Visualizing the Retina

ZEISS AngioPlex OCT Angiography. Clinical Case Reports

IN NICU OCT UTILIZES A CONCEPT KNOWN AS INTERFEROMETRY APPLICATIONS FOR OCT THE PRIMARY USE IN THE EYE - RETINA

Diabetic retinopathy accounts for much of the visual impairment

Macular edema (ME) is the most common

1. AGENCY USE ONLY (Leave blank) 2. REPORT DATE 3. REPORT TYPE AND DATES COVERED FINAL 01 May 93 TO 30 Apr 95. mwwin i ii ^.. IIM«-»- "«'» ' ' i» 1

Multi-Modal Longitudinal Evaluation of Subthreshold Laser Lesions in Human Retina, Including Scanning Laser Ophthalmoscope-Adaptive Optics Imaging

The Foundation WHAT IS THE RETINA? continued next page. RETINA HEALTH SERIES Facts from the ASRS

Diabetic Retinopathy. Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012

Intravitreal Triamcinolone Acetonide for Macular Edema in HLA-B27 Negative Ankylosing Spondylitis

A Patient s Guide to Diabetic Retinopathy

Oishi A, Miyamoto K, Yoshimura N. Etiology of carotid cavernous fistula in Japanese. Jpn J Ophthalmol. 2009;53:40-43.

Acknowledgements. Outline. Who were von Hippel and Lindau? Eugen von Hippel German Ophthalmologist

Citation BioMed Research International, 2015, v. 2015, article no Creative Commons: Attribution 3.0 Hong Kong License

Vitrectomy for Diabetic Cystoid Macular Edema

Diabetic macular edema and its association to systemic risk factors in an urban north Indian population.

Cataract and Diabetic macular edema: What should I do?

Vitrectomy for Diabetic Retinopathy The current role of pars plana vitrectomy for diabetic macular edema and proliferative diabetic retinopathy.

Visual and Anatomical Outcomes of Vitreous Surgery for Large Macular Holes

Low Illumination 3-D Heads-Up Vitrectomy for Diabetic Macular Edema

Transcription:

Assessment of the Morphology of Diabetic Macular Edema Using Optical Coherence Tomography ; Ophthalmologist,DO Al Hindia general hospital/kerbala,iraq Abstract B ackground: Diabetic macular edema(dme) is a major cause of visual loss in patients with diabetes It usually results from the breakdown of the inner blood retinal barrier Early detection of retinal abnormalities is vital in preventing diabetic macular edema and subsequent loss of vision Until recently, the methods available for detecting and evaluating diabetic macular edema were slit-lamp bio microscopy and stereoscopic photography, both of which are limited in detecting earlier retinal changes Optical coherence tomography (OCT) is a new diagnostic imaging modality that provides high-resolution, cross-sectional images of the eye It is proving to be an accurate tool for the early diagnosis, analysis and monitoring of retinopathy It allows not only the qualitative diagnosis of diabetic macular edema, but also the quantitative assessment of edema Objective: To verify different morphological types of diabetic macular edema that needs different treatment strategies Patients and methods: A descriptive observational study was done in the OCT unit of Immam Hussain eye center in Kerbala city from December 2010 to May 2013 OCT done for 420 eyes of 237 patient Cases with low image quality and cases with other eye disease were excluded Results: Of 420 eyes,211 eyes (504%) have OCT morphological appearance of diffuse spongiform DME,115 eyes (275%) mixed spongiform and cystoid edema, 56 eyes (133%) have cystoid changes, and 38 eyes ( 9% ) showed edema with traction at vitreoretinal interface Conclusion: Optical Coherence Tomography based classification of diabetic macular edema is more accurate in identifying the morphological types that need specific regimes of treatment and in the follow up the response to treatment Keywords: diabetic macular edema, Optical coherence tomography, morphology levels of hyperglycaemia, diabetes Introduction duration, severity of DR at baseline, diastolic blood pressure, hyperlipidemia Diabetic macular edema (DME) can cause structural retinal changes severe enough to make it the most common cause of visual loss in patients with diabetes Although the pathogenesis of DME is still not fully understood, it is mainly caused by the breakdown of the inner blood retinal barrier ] 1[ Diabetic macular edema can develop at all stages of diabetic retinopathy (DR), but it appears to occur more frequently as the severity of DR increases Risk factors that contribute to the progression of DME include increasing and the presence of gross proteinuria ] 2[ Diabetic macular edema is defined by retinal thickening involving or threatening the centre of the macula ] 3,4[ The clinical detection and evaluation methods currently used have until recently, been limited to slit-lamp biomicroscopy and stereoscopic photography Routine slit-lamp biomicroscopy can provide information that is useful in the clinical diagnosis of DME However, early detection of macular thickening is hard to estimate using this technique, and both slit-lamp Karbala J Med Vol6, No2, Dec, 2013 1655

biomicroscopy and stereoscopic photography are subjective and insensitive to small changes in retinal thickness ] 5[ Measurement of the integrity of the blood retinal barrier is a valid clinical entity that potentially allows for the detection of early stages of DR Fluorescein angiography is useful for evaluating the severity of the dysfunction in the blood retinal barrier; however, it does not reliably quantify the degree of fluid accumulation in the retina ] 6[ Optical coherence tomography Optical coherence tomography was first commercially available in 1995; there has been tremendous progress in the development of this technology, as there has been in the understanding of the morphological changes associated with many macular diseases, including DME Optical coherence tomography is a diagnostic tool for high-resolution imaging of ocular tissues It produces crosssectional images of optical reflectivity in the retina in a way that is analogous to the ultrasound B-scan ] 5,7[ It can achieve 2- or 3-dimensional cross-sectional imaging of tissue by measuring the echo delay and intensity of back-reflected infrared light from internal tissue structures, rather than acoustic waves from internal tissue structures Optical coherence tomography is based on the principle of low-coherence interferometry, which measures the time of flight delay of light reflected from ocular structures Low-coherence light is produced by a continuous-wave, super luminescent diode source, which is coupled into a fiber optic Michelson interferometer ] 8[ The proportion of the incident light that is directly backscattered by a tissue structure defines the reflectivity of that structure ] 9[ The OCT signal from a particular tissue layer is the combination of its reflectivity and the absorption and scattering properties of the overlying layers Patients and methods Settings and samples: Descriptive observational study for cases selected from OCT unit database in Immam Hussain medical center in kerbala from 27 of December 2010 to 30 May 2013 Participant: Outpatients of Immam Hussain medical center mainly from kerbala city and the surrounding cities Examination done with TOPCON 2000 OCT system, using macula 3D mode with 6mm area of examination at macula with macular preview images We follow movie scan in the OCT to document foveal changes and to verify extrafoveal peripheral edema The TOPCON OCT system has additional property of taking fundus colored photo for each eye which demonstrate feature of diabetic retinopathy and its stage All patients are adults from 21 to 85 years145 of the patients were males, and 92 were females209 of the patients from Kerbala city,the remaining 28 patients from Baghdad, Babylon, Najaf, Wast, Muthana, Missan and Basra Inclusion criteria: type 1 or type 2 diabetes mellitus with clinical evidence of diabetic retinopathy, Exclusion criteria: diseases that cause poor image quality less than 50 (corneal opacity, mild and moderate cataract, intravitreal hemorrhage)cases with other eye diseases (retinal venous occlusion, intraocular inflammation, age related macular degeneration and central serous chorioretinopathy) were excludedcases with previous macular laser were excluded as old laser may increase cystoid changes and make traction worse The OCT images are classified to 4 main categories according to their morphological appearance: Category 1: diffuse spongiform edema in which there is homogenous thickening of the macula with no cystoid changes, cases of focal and multifocal edema were included in this group Category 2: mixed spongiform and cystoid edema which involve mainly diffuse edema with multiple cystoid spaces at the fovea and parafoveal area Karbala J Med Vol6, No2, Dec, 2013 1656

Category 3: cystoid edema which includes cystoid changes at the fovea and parafoveal area Category 4: tractional edema with abnormal vitreomacular interface The data were analyzed by excel sheet and SPSS programs Results All the 420 eyes from 237 included in this study have clinically significant macular edema (CSME) which is morphologically classified to 4 categories About half of the eyes (504%) have diffuse edema In the mixed category (275%) the main feature is spongiform with multiple cystoid spaces which occur mainly with hard exudates at the macula Cystoid edema present in only 133% of eyes, while tractional edema forms about 9% of eyes Table 1 Relations between gender of the patients in the study Category No Total male eyes Total female eyes Category 1 104 107 Category 2 61 54 Category 3 36 20 Category 4 10 21 P- value for gender of the patient equal to 0182 which is not significant Table 2 Relations between sides of the eye of the patients in the study Category No RE LE Category 1 110 101 Category 2 56 59 Category 3 26 30 Category 4 17 21 P- value for the side of the eye of the patient is not significant Table 3 Summary of the patients age in the study Age group No of patients Percentage of patient Less than 13 55% 40 years 40-49 27 114% 50-59 117 494% More than 60 years 80 338% Mean age of the patients is 551 years Different treatment strategies can be planed accurately with or without macular laser therapy to achieve better results and rapid response Discussion Diabetic macular edema is one of the most significant causes of new blindness and severe visual impairment in patients with diabetes, which can result in reduced quality of life ] 11[ Early detection of retinal abnormalities is vital in preventing DME and subsequent loss of vision Assessment of retinal thickness as well as morphological type of the edema is important for treatment and follow-up ] 11[ Karbala J Med Vol6, No2, Dec, 2013 1657

Although slit lamp biomicroscopy is highly sensitive for qualitative detection of CSME and FFA for detection of fluid leakage, various studies have ascertained that qualitative assessment and quantitative measurement of retinal thickening may correlate better with retinal dysfunction in patients with CSME ] 5[ The sensitivity of OCT to detect DME is very high (986%), comparing to slit-lamp biomicroscopy OCT can detect macular thickening while the clinical examination still normal OCT can detect subclinical DME which have thickness between 200um-300um while slit-lamp biomicroscopy detect only 14% from these cases ] 6[ OCT enables the clinician to study their effects and show accurate subclinical retinal changes that may not be even detectable in FFA It can show extrafoveal edema, and vitreoretinal interface relationship It is approved that retinal thickness should increase between 13-15 of its size in order to be seen by slit lamp biomicroscopy ] 6[ With the advent of newer medical therapies, intravitreal triamcinolone, posterior subtenons injection of triamcinolone, intravitreal anti-vascular endothelial growth factor therapy and vitrectomy for CSME, the role of macular laser in the management of CSME is better reserved for selected groups of patients In this study, we found that about 504 % of eyes have diffuse spongiform edema, 275 % have mixed spongiform and cystoid edema, 133 % have cystoid changes, and 9% of eyes showed tractional edema In Kerala university study; all patient (100%) have macular thickening and spongy edema, in this category, all eyes showed diffuse thickening of macula with small cystic spaces involve features of category 1 and category 2 in our study38% have cystoids edema while 10% of the patients have traction at vitreomacular interface ] 5[ In Tunisian military department of ophthalmologist study, the OCT morphological features classified to 5 main types: Type 1: focal macular thickening (303%) Type 2: diffuse thickening without cysts (209%) These 2 types have the same features of category 1 in our study Type 3: diffuse cystoids macular edema (357%) Type 4: tractional macular edema (131%) ] 6[ This classification is important, because macular laser can benefit mainly focal and multifocal extrafoveal edema, and of little benefit on cystoid edema and it may worsen tractional edema in addition to its known retinal complications ] 12,13[ Diffuse spongiform and mixed edema can benefit from peri-ocular or intravitreal triamcinolone and intravitreal anti-vascular endothelial growth factor inhibitors ] 14[ Sever mixed edema needs repeated intravitreal injections followed by macular grid laser after decrease of macular thickness to less than 300 um ] 15[ Cystoid edema has better response to periocular or intravitreal injections because it improves visual acuity and reduces central macular thickness more than macular laser treatment ] 16[ Vitrectomy is the main treatment for tractional edema it may made worse by macular laser treatment ] 17,18[ Conclusion Optical Coherence Tomography based classification of diabetic macular edema is more accurate in identifying the morphological type that needs specific regime of treatment and in the follow up the response to treatment References 1 Massin P,Girach A,Erginay A,gaudric A; Optical coherence tomography: a key to the future management of patients with diabetic Karbala J Med Vol6, No2, Dec, 2013 1658

macular edema, department of ophthalmology,lariboisiere hospital, Paris, France Acta Ophthalmol scaned2006 Aug;84(4):466-74 2 Ding J Wong TY; Current epidemiology of diabetic retinopathy and diabetic macular edema Singapore Eye Research Institute, National Eye Centre, Singapore 2012 Aug; 12(4):346-54 doi: 101007/s11892-012-0283-6 3 Kanski J J, Brad Bowling clinical ophthalmology, 7 th edition, Page 611 printed in 2011 4 Joseph R and Carol M; Diabetic macular edema, Duane s Ophthalmology on CD ROM 2006, Foundation Volume 2, Chapter113D 5 Anu P, Manoj S, Nair K; OCT Classification of Clinically Significant Macular Edema, Kerala Journal of Ophthalmology, Vol XIX, No 1 6 Maalej A, Cheima W, Asma KH, Riadh R and Salem G; Optical Coherence Tomography for Diabetic Macular Edema: Early Diagnosis, Classification and Quantitative Assessment, Military Department of Ophthalmology (Tunis), Tunisia, J Clinic Experiment Ophthalmol 2012, S: 2 7 Miller D, and Schor P; Optical Coherance Tomography, Duane s Ophthalmology on CD ROM 2006, Volume 1, Chapter31,physical optics 8 James G,Cotas P,Stephen A, and Mark E; Optical Coherance Tomography: An Emerging technology for Biomedical Imaging and Optical biopsy, department of electrical engineering and computer science and research laboratory of electronics, Cambridge Review article, Neoplasia Vol2, Nos1-2, January- April 2000 Pages 9-25 9 Wolfgang D, Morgner U, Ravi K, Franz X, Joel S, and James G; Ultrahigh-resolution ophthalmic optical coherence tomography, Department of Electrical Engineering and Computer Science and Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA, Nat Med 2001 April ; 7(4): 502 507 10 Wyatt B, Robert M, Christina J; Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema, Casey Eye Institute, Oregon Health and Science University, Portland, OR, USA, open access to scientific and medical research,23 May 2013 11 Panozzo G, Parolini B, Gusson E; diabetic macular edema: an OCT-based classification Semin Ophthalmol 2004 Mar-Jun; 19 (1-2):13-20 12 Edmin G; Complication of retinal laser photocoagulation article at link http://emedicinemedscapecom/article/184429 4-overview#showall updated in April 2013 13 Amol D, and Michael S; Diabetic Macular Edema Therapeutic Options, Published online 2012 March 6 doi: 101007/s13300-012-0002- y 14 Ford JA, Lois N, Royle P; Current treatments in diabetic macular edema: systematic review and meta-analysis doi: 101136/BMJ open- 2012-002269 15 Solaiman KA, Diab MM, Dabour SA; repeated intravitreal bevacizumab injection with and without macular grid photocoagulation for treatment of diffuse diabetic macular edema, Department of Ophthalmology, Zagazig University, Zagazig, Egypt; Department of Ophthalmology, Ain Shams University, Cairo, Egypt Retina 2013 Mar 27 16 Avitabile T, Longo A, Reibaldi A; Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema Am J Ophthalmology 2005 Oct; 140(4):695-702 17 Kanski J J, Brad Bowling clinical ophthalmology, 7 th edition, Page 545 printed in 2011 18 Steven R Sanisli and Marks S ; Primary indication for vitreoretinal surgery, Duane s Ophthalmology on CD ROM 2006, Volume 6, Chapter57, Diabetic vitrectomy Karbala J Med Vol6, No2, Dec, 2013 1659